The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Archive for December, 2012

    Dietary fructose and the risk of metabolic diseases

    Saturday, December 29th, 2012

    Concern arises from the increased use of fructose and high-fructose corn syrup as a sweetener.

    Researchers in Switzerland and Belgium reviewed the evidence.

    Here’s what we know. (more…)

    Diets for multiple sclerosis

    Thursday, December 20th, 2012

    Diets and dietary supplements are often used by people with multiple sclerosis (MS).

    This updated Cochrane review reports on studies of dietary habits as an effective treatment for MS patients. (more…)

    Ginkgo biloba fails to prevent Alzheimer’s disease

    Monday, December 17th, 2012

    Researchers in France participating in the GuidAge Study Group assessed the long-term use of standardized ginkgo biloba extract in elderly adults with memory complaints. (more…)

    A role for cognitive behavioral therapy in treatment-resistant depression

    Saturday, December 8th, 2012

    Only a third of patients with depression respond fully to antidepressant drugs, and little evidence exists regarding the best next-step treatment for patients with resistant symptoms.

    Researchers in the CoBalT study (Cognitive Behavioural Therapy) at the University of Bristol in England examined cognitive behavioral therapy (CBT) as an adjunct to usual care (including pharmacotherapy) for primary care patients with treatment-resistant depression compared with usual care alone. (more…)